MX2018001528A - Composicion farmaceutica que comprende sumatriptan para tratamiento de migraña. - Google Patents

Composicion farmaceutica que comprende sumatriptan para tratamiento de migraña.

Info

Publication number
MX2018001528A
MX2018001528A MX2018001528A MX2018001528A MX2018001528A MX 2018001528 A MX2018001528 A MX 2018001528A MX 2018001528 A MX2018001528 A MX 2018001528A MX 2018001528 A MX2018001528 A MX 2018001528A MX 2018001528 A MX2018001528 A MX 2018001528A
Authority
MX
Mexico
Prior art keywords
sumatripan
treating migraine
pharmaceutical composition
sumatriptan
composition
Prior art date
Application number
MX2018001528A
Other languages
English (en)
Inventor
Gupta Piyush
Singh Raghuvanshi Rajeev
Prabhakara Prabhu
Ramesh Patil Rajesh
N Namboodiripad Anil
Original Assignee
Dr Reddy´S Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Reddy´S Laboratories Ltd filed Critical Dr Reddy´S Laboratories Ltd
Priority claimed from PCT/US2016/015961 external-priority patent/WO2017023361A1/en
Publication of MX2018001528A publication Critical patent/MX2018001528A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente solicitud se relaciona a un método de tratamiento de migraña o terrible dolor de cabeza en un paciente humano, el método que comprende administrar la vcomposición subcutáneamente que comprende sumatriptán o su sal farmacéuticamente aceptable, en una cantidad equivalente a 3 mg de base de sumatriptán.
MX2018001528A 2015-08-05 2016-02-01 Composicion farmaceutica que comprende sumatriptan para tratamiento de migraña. MX2018001528A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN4076CH2015 2015-08-05
US15/011,357 US10537554B2 (en) 2015-08-05 2016-01-29 Pharmaceutical composition for treating migraine
PCT/US2016/015961 WO2017023361A1 (en) 2015-08-05 2016-02-01 Pharmaceutical composition comprising sumatripan for treating migraine

Publications (1)

Publication Number Publication Date
MX2018001528A true MX2018001528A (es) 2018-04-24

Family

ID=58053922

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018001528A MX2018001528A (es) 2015-08-05 2016-02-01 Composicion farmaceutica que comprende sumatriptan para tratamiento de migraña.

Country Status (6)

Country Link
US (3) US10537554B2 (es)
EP (1) EP3331524A1 (es)
CN (1) CN107921023A (es)
BR (1) BR112018002433A2 (es)
CA (1) CA2994748C (es)
MX (1) MX2018001528A (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10537554B2 (en) 2015-08-05 2020-01-21 Upsher-Smith Laboratories, Llc Pharmaceutical composition for treating migraine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR79215B (es) * 1982-06-07 1984-10-22 Glaxo Group Ltd
US10537554B2 (en) 2015-08-05 2020-01-21 Upsher-Smith Laboratories, Llc Pharmaceutical composition for treating migraine

Also Published As

Publication number Publication date
US11364224B2 (en) 2022-06-21
US10537554B2 (en) 2020-01-21
US20200171000A1 (en) 2020-06-04
BR112018002433A2 (pt) 2018-09-18
CN107921023A (zh) 2018-04-17
US20170035729A1 (en) 2017-02-09
EP3331524A1 (en) 2018-06-13
CA2994748C (en) 2024-02-13
US20220387386A1 (en) 2022-12-08
CA2994748A1 (en) 2017-02-09

Similar Documents

Publication Publication Date Title
PH12020500066A1 (en) Carboxamides as modulators of sodium channels
MX2021000071A (es) Uso de pridopidina para mejorar la funcion cognitiva y para tratamiento de enfermedad de alzheimer.
PH12017502142A1 (en) Tetrasubstituted aklene compounds and their use
JOP20160092B1 (ar) علاج البيتا ثلاسيميا باستخدام مصطبة لجائنية
MX2022003072A (es) Uso de pridopidina para el tratamiento de la disminucion funcional.
PH12016502352A1 (en) Pharmaceutical composition
PH12016502353A1 (en) Pharmaceutical composition
MX2021002321A (es) Nuevos metodos.
MA39765A (fr) Formulation pharmaceutique d'un inhibiteur de la kinase pan-raf, ses procédés de préparation, et procédés d'utilisation
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
MX2022015629A (es) Uso de vibegron para tratar vejiga sobreactiva.
MX2019005160A (es) Formulacion farmaceutica.
MX2022014792A (es) Cocristales, composiciones farmaceuticas de los mismos y metodos de tratamiento que los implican.
MX2018014129A (es) Composiciones farmaceuticas de oligomero de morfolino fosforodiamidato.
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
MX2014014814A (es) Composicion farmaceutica para el tratamiento de inflamacion y dolor.
SG10201809673RA (en) Treatment of androgen deprivation therapy associated symptoms
MX2018001528A (es) Composicion farmaceutica que comprende sumatriptan para tratamiento de migraña.
MX2023005014A (es) Metodos de tratamiento de enfermedades inflamatorias cronicas.
MX2020001217A (es) Metodos de tratamiento de sintomas de gastroparesia usando velusetrag.
EA201590760A1 (ru) Применение бремеланотида в терапии женской сексуальной дисфункции
MX2016010919A (es) 4-bencilsulfonil-2-butenonitrilo.
UA82584U (ru) Способ лечения вестибулярной мигрени и коморбидного синдрома головокружения у женщин с вестибулярной дисфункцией в перименопаузальном периоде
MX2015014707A (es) Proceso de obtencion y composicion farmaceutica de esomeprazol inyectable para el tratamiento de trastornos gastricos.